{"id":40157,"date":"2026-01-06T11:47:33","date_gmt":"2026-01-06T10:47:33","guid":{"rendered":"https:\/\/www.transgene.com\/?p=40157"},"modified":"2026-01-06T11:49:41","modified_gmt":"2026-01-06T10:49:41","slug":"search-categorie","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/search-categorie\/","title":{"rendered":"cherche Categorie"},"content":{"rendered":"<ul class=\"lcp_catlist\" id=\"lcp_instance_0\"><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250206_TRANSGENE_Eligibilite-PEA-PME_FR.pdf\" title=\"L&rsquo;action Transgene (Euronext Paris : TNG) \u00e9ligible au dispositif du PEA-PME\"><div class='catlistdate'>6 f\u00e9vrier 2025<\/div>  <div class='catlistTitle'>L&rsquo;action Transgene (Euronext Paris : TNG) \u00e9ligible au dispositif du PEA-PME<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250121_Transgene_Prochains-RDV-Investisseurs_FR.pdf\" title=\"Transgene participera \u00e0 la conf\u00e9rence investisseurs Biomed Forum\"><div class='catlistdate'>21 janvier 2025<\/div>  <div class='catlistTitle'>Transgene participera \u00e0 la conf\u00e9rence investisseurs Biomed Forum<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250114_TRANSGENE_Agenda_Financier_2025_FR.pdf\" title=\"Transgene pr\u00e9sente son calendrier de communication financi\u00e8re pour 2025\"><div class='catlistdate'>14 janvier 2025<\/div>  <div class='catlistTitle'>Transgene pr\u00e9sente son calendrier de communication financi\u00e8re pour 2025<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/static1.squarespace.com\/static\/56dee71e555986fb3ae583e2\/t\/66db4e7cb9451f7aac7fcd10\/1725648512282\/CICON24+Abstracts+FINAL+090524+v4.pdf\" title=\"TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment\"><div class='catlistdate'>10 septembre 2024<\/div>  <div class='catlistTitle'>TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/jitc.bmj.com\/content\/jitc\/12\/7\/e009302.full.pdf\" title=\"TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment\"><div class='catlistdate'>27 ao\u00fbt 2024<\/div>  <div class='catlistTitle'>TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20240827_TRANSGENE_TG6050-JITC-FR.pdf\" title=\"Transgene publie dans le JITC des donn\u00e9es de preuve de concept pr\u00e9clinique du virus oncolytique TG6050\"><div class='catlistdate'>27 ao\u00fbt 2024<\/div>  <div class='catlistTitle'>Transgene publie dans le JITC des donn\u00e9es de preuve de concept pr\u00e9clinique du virus oncolytique TG6050<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230510_Transgene_TG6050_Delivir_trial_FPI_FR.pdf\" title=\"Transgene &#8211; Premier patient trait\u00e9 dans l&rsquo;essai de Phase I \u00e9valuant TG6050, un virus oncolytique innovant arm\u00e9 avec de l&rsquo;IL-12, dans le cancer du poumon non \u00e0 petites cellules\"><div class='catlistdate'>10 mai 2023<\/div>  <div class='catlistTitle'>Transgene &#8211; Premier patient trait\u00e9 dans l&rsquo;essai de Phase I \u00e9valuant TG6050, un virus oncolytique innovant arm\u00e9 avec de l&rsquo;IL-12, dans le cancer du poumon non \u00e0 petites cellules<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230417_Transgene_AACR_TG6050_FR.pdf\" title=\"Pr\u00e9sentation \u00e0 l&rsquo;AACR de r\u00e9sultats pr\u00e9cliniques montrant que TG6050, un virus oncolytique innovant, induit une r\u00e9gression tumorale gr\u00e2ce \u00e0 l&rsquo;activation des r\u00e9ponses immunitaires inn\u00e9es et adaptatives\"><div class='catlistdate'>17 avril 2023<\/div>  <div class='catlistTitle'>Pr\u00e9sentation \u00e0 l&rsquo;AACR de r\u00e9sultats pr\u00e9cliniques montrant que TG6050, un virus oncolytique innovant, induit une r\u00e9gression tumorale gr\u00e2ce \u00e0 l&rsquo;activation des r\u00e9ponses immunitaires inn\u00e9es et adaptatives<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/Transgene_AACR2023_TG6050_TME_remodeling_poster.pdf\" title=\"TG6050 an oncolytic vaccinia virus armed with interleukin 12 and anti-CTLA4 antibody induces TME remodeling and strong anti-tumoral responses\"><div class='catlistdate'>16 avril 2023<\/div>  <div class='catlistTitle'>TG6050 an oncolytic vaccinia virus armed with interleukin 12 and anti-CTLA4 antibody induces TME remodeling and strong anti-tumoral responses<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230315_-_AACR_Curtain_raiser_FR.pdf\" title=\"Transgene pr\u00e9sentera plusieurs posters soulignant le potentiel de son portefeuille d&rsquo;immunoth\u00e9rapies \u00e0 l&rsquo;AACR 2023\"><div class='catlistdate'>15 mars 2023<\/div>  <div class='catlistTitle'>Transgene pr\u00e9sentera plusieurs posters soulignant le potentiel de son portefeuille d&rsquo;immunoth\u00e9rapies \u00e0 l&rsquo;AACR 2023<\/div><\/a><\/li><li><a class=\"count\" onclick=\"count()\" href=\"https:\/\/www.transgene.com\/CP.php?f=31245&amp;link=20230106_Transgene_TG6050_Delivir_ANSM_FR.pdf\" title=\"Transgene re\u00e7oit l&rsquo;autorisation de lancer un essai de Phase I avec TG6050, un virus oncolytique innovant arm\u00e9 avec de l&rsquo;IL-12 et administr\u00e9 par voie intraveineuse\"><div class='catlistdate'>6 janvier 2023<\/div>  <div class='catlistTitle'>Transgene re\u00e7oit l&rsquo;autorisation de lancer un essai de Phase I avec TG6050, un virus oncolytique innovant arm\u00e9 avec de l&rsquo;IL-12 et administr\u00e9 par voie intraveineuse<\/div><\/a><\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-40157","post","type-post","status-publish","format-standard","hentry","category-non-classifiee","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/40157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=40157"}],"version-history":[{"count":3,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/40157\/revisions"}],"predecessor-version":[{"id":40160,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/40157\/revisions\/40160"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=40157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=40157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=40157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}